Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q: What does CUSIP 221015100 represent in this 13F holders report?

CUSIP 221015100 is the security identifier for CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2021?

44 institutional investors reported CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 221015100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 91,091,040
Total 13F shares: 23,673,230
Share change: +3,279,406
Total reported value: $63,207,000
Put/Call ratio: 310%
Price per share: $2.67
Number of holders: 44
Value change: +$8,569,595
Number of buys: 15
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 221015100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	8.8%	8,053,298	$24,804,000	—	31 Mar 2021	13F
ADAMS STREET PARTNERS LLC	13F	Company	3.6%	3,275,616	$10,089,000	—	31 Mar 2021	13F
BVF INC/IL	13F	Company	3.5%	3,229,426	$9,947,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	1.1%	1,000,119	$3,081,000	—	31 Mar 2021	13F
CHI Advisors LLC	13F	Company	0.75%	679,132	$2,092,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.73%	663,470	$2,043,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.46%	416,649	$1,283,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.38%	348,756	$1,074,000	—	31 Mar 2021	13F
Bank Julius Baer & Co. Ltd, Zurich	13F	Company	0.37%	336,748	$1,037,000	—	31 Mar 2021	13F
Stonepine Capital Management, LLC	13F	Company	0.35%	316,279	$974,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.32%	292,000	$899,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	0.31%	282,132	$869,000	—	31 Mar 2021	13F
Telemetry Investments, L.L.C.	13F	Company	0.27%	249,006	$767,000	—	31 Mar 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	204,300	$629,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	148,834	$458,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.11%	100,000	$307,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.11%	99,096	$305,000	—	31 Mar 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.1%	95,613	$294,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	91,238	$281,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.09%	77,668	$239,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	64,271	$198,000	—	31 Mar 2021	13F
ALGERT GLOBAL LLC	13F	Company	0.05%	42,857	$132,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0.05%	42,786	$132,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.04%	37,820	$116,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.04%	37,253	$115,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	30,804	$95,000	—	31 Mar 2021	13F
TRUIST FINANCIAL CORP	13F	Company	0.02%	21,000	$65,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.02%	20,936	$64,000	—	31 Mar 2021	13F
Hikari Power Ltd	13F	Company	0.02%	19,959	$61,000	—	31 Mar 2021	13F
NATIXIS	13F	Company	0.02%	16,500	$51,000	—	31 Mar 2021	13F
Windsor Creek Advisors, LLC	13F	Company	0.02%	14,786	$46,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	13,830	$43,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.01%	11,200	$34,000	—	31 Mar 2021	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.01%	10,500	$32,000	—	31 Mar 2021	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	0.01%	10,500	$32,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	9,951	$31,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	9,936	$31,000	—	31 Mar 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	5,886	$18,000	—	31 Mar 2021	13F
WHITTIER TRUST CO OF NEVADA INC	13F	Company	0%	4,200	$13,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0%	3,000	$9,000	—	31 Mar 2021	13F
Rockefeller Capital Management L.P.	13F	Company	0%	2,500	$7,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1,100	$3,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,000	$3,000	—	31 Mar 2021	13F
Cutler Group LLC / CA	13F	Company	0%	800	$2,000	—	31 Mar 2021	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	645	$2,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0%	533	$2,000	—	31 Mar 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0%	446	$1,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	164	$1,000	—	31 Mar 2021	13F

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q2 2021

As of 30 Jun 2021, Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,673,230 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BVF INC/IL, EcoR1 Capital, LLC, ADAMS STREET PARTNERS LLC, VANGUARD GROUP INC, CHI Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-1

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.